Ginsenoside Rb1 inhibits fibrillation and toxicity of alpha-synuclein and disaggregates preformed fibrils-Reference-Cited by-同舟云学术

Ginsenoside Rb1 inhibits fibrillation and toxicity of alpha-synuclein and disaggregates preformed fibrils

Published:2015-02 Issue: Volume:74 Page:89-101
ISSN:0969-9961
Container-title:Neurobiology of Disease
language:en
Short-container-title:Neurobiology of Disease

Author:

Ardah Mustafa T.,Paleologou Katerina E.,Lv Guohua,Menon Sindhu A.,Abul Khair Salema B.,Lu Jia-Hong,Safieh-Garabedian Bared,Al-Hayani Abdulmonem A.,Eliezer David,Li Min,El-Agnaf Omar M.A.

Publisher

Elsevier BV

Subject

Neurology

Reference53 articles.

1. Structure activity relationship of phenolic acid inhibitors of α-synuclein fibril formation and toxicity;Ardah;Front. Aging Neurosci.,2014

2. Ginseng pharmacology: multiple constituents and multiple actions;Attele;Biochem. Pharmacol.,1999

3. Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies;Baba;Am. J. Pathol.,1998

4. A structural and functional role for 11-mer repeats in alpha-synuclein and other exchangeable lipid binding proteins;Bussell;J. Mol. Biol.,2003

5. Inhibition and disaggregation of α-synuclein oligomers by natural polyphenolic compounds;Caruana;FEBS Lett.,2011

Cited by 89 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of Red ginseng on neuroinflammation in neurodegenerative diseases;Journal of Ginseng Research;2024-01

2. Anti-amyloid potential of some phytochemicals against Aβ-peptide and α-synuclein, tau, prion, and Huntingtin protein;Drug Discovery Today;2023-12

3. The Molecular Basis of Wnt/β-Catenin Signaling Pathways in Neurodegenerative Diseases;International Journal of Cell Biology;2023-09-21

4. Integrated Multimodal Omics and Dietary Approaches for the Management of Neurodegeneration;Epigenomes;2023-09-01

5. Integrating Network Pharmacology and Component Analysis to Study the Potential Mechanisms of Qi-Fu-Yin Decoction in Treating Alzheimer’s Disease;Drug Design, Development and Therapy;2023-09